£109.79

Springer Multiple Myeloma and Plasma Cell Neoplasms Book

Price data last checked 64 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 27 days • 27 data points (No recent data available)

Historical
Generating forecast...
£109.79 £104.30 £106.50 £108.69 £110.89 £113.08 £115.28 27 January 2026 02 February 2026 09 February 2026 15 February 2026 22 February 2026

Price Distribution

Price distribution over 27 days • 1 price levels

Days at Price
27 days 0 7 14 20 27 £110 Days at Price

Price Analysis

Most common price: £110 (27 days, 100.0%)

Price range: £110 - £110

Price levels: 1 different prices over 27 days

Description

Stay current with this essential medical resource on plasma cell neoplasms from Springer. This book serves as a comprehensive source of up-to-date information for healthcare professionals managing hematologic malignancies. It provides updated diagnostic frameworks, including new criteria for identifying symptomatic multiple myeloma that requires active treatment. Readers gain access to detailed descriptions of novel therapies recently licensed by the U.S. Food and Drug Administration. The text covers critical advancements in treatment protocols, such as the use of lenalidomide as a first-line therapy. It also examines specialized combinations like panobinostat with bortezomib and dexamethasone for relapsed or refractory cases. Additionally, the book explores the application of ibrutinib for Waldenstrom's macroglobulinemia and other new therapeutic regimens. This volume is a vital addition to any medical library focused on immunology and internal medicine, offering the latest clinical insights into the management of plasma cell disorders.

Key Features

Provides new diagnostic criteria for symptomatic multiple myeloma requiring treatment to assist in accurate clinical assessment.

Covers recently FDA-licensed therapies for myeloma and other plasma cell neoplasms to keep medical practice current.

Details lenalidomide usage as a first-line therapy option for managing patient care effectively.

Includes information on panobinostat in combination with bortezomib and dexamethasone for relapsed or refractory myeloma.

Explains the application of ibrutinib for the treatment of Waldenstrom's macroglobulinemia.

Offers a comprehensive overview of new therapeutic regimens for various hematologic malignancies.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
07 September 2016
Listed Since
10 September 2015

Barcode

No barcode data available

Similar Products You Might Like

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)
100% match

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Springer

£79.70 22 Feb 2026
Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)
95% match

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Springer

£104.67 09 Mar 2026
Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)
95% match

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Springer

£84.27 16 Feb 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
95% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£84.29 08 Mar 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
95% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£103.09 06 Jan 2026
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)
94% match

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)

Springer

£84.59 08 Mar 2026
Treatment of Multiple Myeloma and Related Disorders
94% match

Treatment of Multiple Myeloma and Related Disorders

Cambridge University Press

£36.41 27 Feb 2026
Springer - Advances in Biology and Therapy of Multiple Myeloma 2
94% match

Springer - Advances in Biology and Therapy of Multiple Myeloma 2

Springer

£107.43 01 Mar 2026
Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)
94% match

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

£91.41 10 Mar 2026
Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders
94% match

Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders

Springer

£147.52 10 Jan 2026
Myeloproliferative Neoplasms: Critical Concepts and Management (Hematologic Malignancies)
94% match

Myeloproliferative Neoplasms: Critical Concepts and Management (Hematologic Malignancies)

Springer

£84.25 23 Feb 2026
Myeloproliferative Neoplasms: Biology and Therapy (Contemporary Hematology)
94% match

Myeloproliferative Neoplasms: Biology and Therapy (Contemporary Hematology)

Humana

£79.98 13 Jan 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
94% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£99.53 25 Feb 2026
Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)
94% match

Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)

£134.20 11 Jan 2026
Multiple Myeloma and Related Disorders (Hodder Arnold Publication)
93% match

Multiple Myeloma and Related Disorders (Hodder Arnold Publication)

CRC Press

£146.95 10 Jan 2026
Myeloma Bone Disease (Current Clinical Oncology)
93% match

Myeloma Bone Disease (Current Clinical Oncology)

Humana

£139.86 21 Feb 2026
Biology and Management of Multiple Myeloma (Current Clinical Oncology)
93% match

Biology and Management of Multiple Myeloma (Current Clinical Oncology)

Humana

£67.40 09 Mar 2026
Hematologic Malignancies: An Overview - Hematology Research
93% match

Hematologic Malignancies: An Overview - Hematology Research

Out of Stock 17 Apr 2026
Acute Myeloid Leukemia (Hematologic Malignancies)
93% match

Acute Myeloid Leukemia (Hematologic Malignancies)

£92.25 08 Jan 2026
Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
93% match

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Springer

£92.42 08 Jan 2026
Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics
93% match

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

Springer

£122.70 07 Mar 2026
Myeloproliferative Disorders: Symptoms, Risk Factors and Treatment Options (Recent Advances in Hematology Research)
93% match

Myeloproliferative Disorders: Symptoms, Risk Factors and Treatment Options (Recent Advances in Hematology Research)

Nova Science Publishers Inc

£47.46 22 Feb 2026
Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics
93% match

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

£116.62 13 Jan 2026
Managing Myeloproliferative Neoplasms: A Case-Based Approach
93% match

Managing Myeloproliferative Neoplasms: A Case-Based Approach

Cambridge University Press

£52.33 08 Mar 2026